Lab Information
Évelyne Vinet (MD/PhD)
ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
Keywords
Systemic lupus erythematosus • rheumatoid arthritis • female reproductive health • epidemiology • pregnancy and rheumatic diseases • administrative databases • perinatal outcomesResearch Interests
The primary goal of my research program is to use epidemiologic methods to improve reproductive health outcomes in women with rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and their offspring. To this end, I have created the world's largest cohort of offspring from SLE women, which has driven our novel findings demonstrating that SLE offspring are at increased risk of autism spectrum disorders, congenital heart defects, and stillbirths. I am also actively spear-heading research initiatives to elucidate how therapies used to treat rheumatic diseases (e.g. TNF-inhibitors and other biologics) impact health outcomes in these patients and their offspring.Research areas: Clinical Epidemiology; Rheumatic Diseases; Non-Communicable Disease Epidemiology; Pharmacoepidemiology; Population and Public Health
Team Members
| Name | Position |
|---|
Latest Publications
- Kundakci, B., Barber, M. R. W., Clarke, A. E., Johnson, S. R., Mak, A., Brunner, H. I., Inanc, M., Ramsey-Goldman, R., Ruiz-Irastorza, G., Ginzler, E. M., Hanly, J. G., Legge, A., Aranow, C., Arnaud, L., Costedoat-Chalumeau, N., Gladman, D. D., Jacobsen, S., Petri, M. A., Silva, C. A., Vinet, E., Voskuyl, A. E., SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Bruce, I. N. & Supported by the Lupus Foundation of America (2026). The lupus damage index revision program: Results from the item generation and reduction phases. Lupus science & medicine, vol. 13.
- Kundakci, B., Barber, M. R. W., Clarke, A. E., Johnson, S. R., Mak, A., Brunner, H. I., Inanc, M., Ramsey-Goldman, R., Ruiz-Irastorza, G., Ginzler, E. M., Hanly, J. G., Legge, A., Aranow, C., Arnaud, L., Costedoat-Chalumeau, N., Gladman, D. D., Jacobsen, S., Petri, M., Silva, C. A., Vinet, É., Voskuyl, A. E., SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups & Bruce, I. N. (2026). The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases. Arthritis care & research.
- Stein, O. A., Lee, J. L., Vinet, E., Mendel, A., Pineau, C. A., Kalache, F., Grenier, L.-P. & Bernatsky, S. (2026). Artificial Intelligence-based Online Symptom Assessment Tools for Systemic Lupus Erythematosus (SLE) diagnosis: Patient Perspectives. Arthritis care & research.
- Farhat, R., Zamora-Medina, M. D. C., Bae, S.-C., Barber, M. R. W., Clarke, A. E., Fortin, P. R., Touma, Z., Laskin, C. A., Malhamé, I., Sebastiani, G., Peschken, C., Ugarte-Gil, M. F., Legge, A., Bernatsky, S. & Vinet, É. (2026). Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine. Arthritis & rheumatology (Hoboken, N.J.).
- Barber, M. R. W., St Pierre, Y., Peschken, C. A., Legge, A., Hanly, J. G., Vinet, E., Pineau, C. A., Bernatsky, S., Touma, Z., Urowitz, M. B., Gladman, D. D., Fortin, P. R. & Clarke, A. E. (2026). Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort. Lupus science & medicine, vol. 13.
- Flatman, L. K., Beauchamp, M.-E., St-Pierre, Y., Malhamé, I., Bérard, A., Bernatsky, S. & Vinet, É. (2026). Diarrhoea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study. Rheumatology (Oxford, England), vol. 65.
- Stein, O. A., Lee, J. L. F., Vinet, E., Mendel, A., Pineau, C. A., Kalache, F., Grenier, L.-P., Mielczarek, L. & Bernatsky, S. (2026). Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus. Rheumatology international, vol. 46, p. 34.
- Flatman, L. K., Bernatsky, S., St-Pierre, Y., Beauchamp, M.-E., Malhamé, I., Bérard, A. & Vinet, É. (2026). Serious Infections in Offspring Exposed to Tumour Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability. Arthritis & rheumatology (Hoboken, N.J.), vol. 78, p. 976-984.
- Aly, S., Parastandehchehr, G., Bernatsky, S., Vinet, É., Arnaud, L., Costedoat-Chalumeau, N., Fortin, P. R., Reynolds, J. A., Thorne, C., Touma, Z., Wallace, D., Werth, V. P., Singer, W. & Mendel, A. (2026). A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus. The Journal of rheumatology, vol. 53, p. 292-296.
- Flatman, L. K., Beauchamp, M.-E., St-Pierre, Y., Malhamé, I., Bérard, A., Bernatsky, S. & Vinet, É. (2025). Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases. ACR open rheumatology, vol. 7, p. e70117.
See also
